Functional study of mitotic checkpoint in human embryonic stem cells
Functional study of mitotic checkpoint in human embryonic stem cells
批准号:
MR/K008897/1
负责人:
Peter Walter Andrews
金额:
$3.78万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
已经确定,人ES细胞(hESC)和iPS细胞在长期培养期间可以获得染色体异常。这些变化包括整个或部分染色体的获得以及结构重排。核型异常的人胚胎干细胞通常表现出肿瘤转化和分化缺陷的迹象,因此它们可能对其在再生医学中的潜在用途构成重大危险,而这些变化可能影响它们在其他应用中的使用,包括毒理学,药物发现和疾病建模。这些涉及DNA重排的染色体变化可能是由细胞周期S期DNA合成过程中的缺陷引起的。然而,许多变化涉及整个染色体的获得,强烈表明这些变化是由有丝分裂缺陷引起的,导致染色体非异常连接和染色体向子细胞的不均匀分布。有可能的是,有丝分裂机制,特别是纺锤体组装检查点,其管理姐妹染色单体的相等分离,在ES细胞中与体细胞不同,反映了早期胚胎的特定要求,并且据报道,检查点-凋亡解偶联发生在人类和小鼠ESC中,但潜在的分子机制尚未探索。在这个项目中,我们将集中在极光激酶的表达和作用,这是细胞分裂的关键调节器。它们通常在癌细胞中高度表达,在我们以前的研究中,我们还发现它们也在早期哺乳动物胚胎和胚胎干细胞中富集。这种富集可能与胚胎细胞的快速细胞分裂速率有关,但也可能使这些细胞容易受到有丝分裂检查点的错误调节,从而导致染色体异常的积累。特别是,Aurora激酶C,一种通常在生殖细胞中表达的Aurora激酶,在小鼠植入前发育期间与Aurora B具有重叠以及不同的功能,并且Aurora C的存在可能有助于hESC中有丝分裂检查点的独特性质。我们将采用小分子抑制、siRNA敲低和mRNA过表达等方法来破坏Aurora B和C的功能,研究其对hESC凋亡、自我更新和分化的短期和长期影响。这些结果将为深入了解hESC中有丝分裂检查点的功能提供帮助,并有助于为减少或预防hESC中核型异常的发生和提高其基因组稳定性提供信息。
英文摘要
It is well established that human ES cells (hESC), and iPS cells, can gain chromosomal abnormalities during prolonged culture. These changes include the gain of whole or partial chromosomes as well as structure rearrangements. Karyotypically abnormal hESC often show signs of neoplastic transformation and defects in differentiation, so that they may pose significant dangers for their potential use in regenerative medicine, while these changes may affect their use in other applications including toxicology, drug discovery and disease modelling. It seems likely that those chromosomal changes that involve rearrangements of the DNA result from defects during DNA synthesis in S phase of the cell cycle. However, many changes involve the gain of whole chromosomes, strongly suggesting that these changes arise from defects at mitosis resulting in chromosomal non-dysjunction and unequal distributions of chromosome to the daughter cells. It is likely that the mitotic machinery, particularly the spindle assembly checkpoint, which governs the equal separation of the sister chromatids, is different in ES cells from somatic cells, reflecting specific requirements in the early embryo and it is reported that checkpoint-apoptosis uncoupling occurs in human and mouse ESCs, but the underlying molecular mechanism remains unexplored. In this project we will focus on the expression and role of the Aurora kinases which are key regulators of cell division. They are often highly expressed by cancer cells and in our previous studies we also found that they are also enriched in early mammalian embryos and embryonic stem cells. This enrichment may be associated with the fast cell division rate of embryonic cells, but may also make these cells susceptible to the mis-regulation of the mitotic checkpoint resulting in the accumulation of chromosomal abnormality. In particular, Aurora kinase C, an Aurora kinase normally expressed in germ cells, has overlapping as well as distinct functions from Aurora B during mouse preimplantation development and the presence of Aurora C may contribute to the unique properties of mitotic checkpoint in hESCs. We will use small molecule inhibition, siRNA knocking-down and mRNA over expression to disrupt the function of Aurora B and C and study the short-term and long-term effects on hESC apoptosis, self-renewal and differentiation. The results will provide insights into the function of mitotic checkpoints in hESCs and help inform approaches to reduce or prevent the occurrence of karyotype abnormality in hESCs and improve their genome stability.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Aneuploidy in pluripotent stem cells and implications for cancerous transformation.
多能干细胞的非整倍性及其对癌变的影响。
DOI:
10.1007/s13238-014-0073-9
发表时间:
2014
期刊:
PROTEIN & CELL
影响因子:
21.1
作者:
[Na, Jie, Baker, Duncan, Zhang, Jing, Andrews, Peter W., Barbaric, Ivana]
通讯作者:
Barbaric, Ivana
The Pluripotent Stem Cell Platform (PSCP)
-
批准号:MR/L012537/1
-
项目类别:Research Grant
-
资助金额:$600.33万
-
财政年份:2014
-
负责人:Peter Walter Andrews
-
依托单位:
Pluripotent Stem Cell Platform -Capital Investment
-
批准号:MR/L012650/1
-
项目类别:Research Grant
-
资助金额:$393.77万
-
财政年份:2013
-
负责人:Peter Walter Andrews
-
依托单位:
Quantitative mapping of the proteomes of therapeutic stem cells.
-
批准号:BB/J021407/1
-
项目类别:Research Grant
-
资助金额:$34.89万
-
财政年份:2012
-
负责人:Peter Walter Andrews
-
依托单位:
Culture Adaptation in Human Embryonic Stem Cell Lines
-
批准号:G0700785/1
-
项目类别:Research Grant
-
资助金额:$177.91万
-
财政年份:2008
-
负责人:Peter Walter Andrews
-
依托单位:
The Development of High Throughput Automated Microscopy to Investigate the Developmental Genetics of Model Organisms
-
批准号:BB/D524908/1
-
项目类别:Research Grant
-
资助金额:$17.21万
-
财政年份:2006
-
负责人:Peter Walter Andrews
-
依托单位:
Identifying chemical agents that affect human embryonic stem cells in vitro and determining their molecular targets.
-
批准号:BB/D006120/1
-
项目类别:Research Grant
-
资助金额:$33.86万
-
财政年份:2006
-
负责人:Peter Walter Andrews
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Incentive and governance schenism study of corporate green washing behavior in China: Based on an integiated view of econfiguration of environmental authority and decoupling logic
-
批准号:--
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:YU BYUNGJUN
-
依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
含Re、Ru先进镍基单晶高温合金中TCP相成核—生长机理的原位动态研究
-
批准号:52301178
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:夏万顺
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
丁酸梭菌代谢物(如丁酸、苯乳酸)通过MYC-TYMS信号轴影响结直肠癌化疗敏感性的效应及其机制研究
-
批准号:82373139
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:李孟鸿
-
依托单位:
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
-
批准号:82371150
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯书乐
-
依托单位: